1. Alexander, J., 1979, Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BABL/c mice, Clin. Exp. Immunol.34:52–58.
2. Alexander, J., and Curtis, J., 1979, Development of delayed hypersensitivity responses to Mycobacterium lepraemurium infections in resistant and susceptible strains of mice, Immunology 36:563–567.
3. Barnetson, R. St.C., Bjune, G., Pearson, J. M. H., and Kronvall, G., 1975, Antigenic heterogeneity in patients with reactions in borderline leprosy, Br. Med. J.4:435–437.
4. Bechelli, L. M., Garbajosa, P. G., Gyi, M. M., Uemura, K., Sundarasan, T., Dominguez, V. M., Matejka, M., Tamondon, C., Quagliato, R., Engler, V., and Altmann, M., 1973, BCG vaccination of children against leprosy: Seven year findings of the controlled WHO trial in Burma, Bull. WHO 48:323–334.
5. Bjorvain, B., Barnetson, R. S., Kronvall, G. K., Zubler, R. H., and Lambert, P. H., 1976, Immune complexes and complement hypercatabolism in patients with leprosy, Clin. Exp. Immunol.26:388–396.